Skip to content
Screener

uniQure QURE Net Change in Cash

Net Change in Cash at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$336.83M+60.9%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-$43.19M-92.4%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$147.9M-121%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
-$4.09M+54.1%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$75.1M+816%
Regenxbio logo
RegenxbioRGNX
$21.26M

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemSix months ended June 30, 2026Six months ended June 30, 2025
Proceeds from issuance of ordinary shares related to employee stock options and purchase plans6,985203
Net cash generated from financing activities249,66680,714
Currency effect on cash, cash equivalents and restricted cash(1,906)5,052
Net increase in cash, cash equivalents and restricted cash332,76094,943
Cash, cash equivalents and restricted cash at the beginning of period81,801160,329
Cash, cash equivalents and restricted cash at the end of period$414,561$255,272
Cash and cash equivalents$413,027$253,778
Restricted cash related to leasehold and other deposits1,5341,494

Item 1.Financial Statements

FAQ

What is uniQure's net change in cash?
uniQure (QURE) reported net change in cash of $273.03M in Q2 2026.
How has uniQure's net change in cash changed year-over-year?
uniQure's net change in cash increased by 645.7% year-over-year, from $36.61M to $273.03M.
What is the long-term trend for uniQure's net change in cash?
Over 2 years (2022 to 2025), uniQure's net change in cash has grown at a -51.1% compound annual growth rate (CAGR), from -$328.18M to -$78.53M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about uniQure's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude